BSE filing, BSE: 542934. Summary written from the filing by ALFA Finder's alert engine.
Chandra Bhagat Pharma Ltd: key numbers
- Share price
- ₹55.50
- Market cap
- ₹41.88 Cr
- Revenue (annual)
- ₹116.3 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 13.8×Sector 43.0×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandra Bhagat Pharma Ltd
All →Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 50 lakh convertible warrants worth ₹21.90 Crore to seven promoter group members. Allotment was completed on 22 October 2026.
- Value
- ₹21.90 Cr
Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 66 lakh convertible warrants at Rs.44 each, raising Rs.7.26 Crore from 9 allottees. Warrants are convertible 1:1 into equity shares within 18 months.
- Value
- ₹7.26 Cr
Chandra Bhagat Pharma Other Announcement
Chandra Bhagat Pharma Ltd filed a certificate for non-applicability of corporate governance requirements for the September 2026 quarter. This exemption applies to SME-listed entities.
Chandra Bhagat Pharma Preferential Issue
Chandra Bhagat Pharma received BSE in-principle approval for a preferential issue of 66,00,000 warrants at Rs. 44 each. Total issue value is approximately Rs. 2.90 Crore.
- Value
- ₹2.90 Cr
Chandra Bhagat Pharma Management Change
Ms. Rajani Dawani has resigned from her position as Company Secretary and Compliance Officer of Chandra Bhagat Pharma Limited, effective September 30, 2026.
Chandra Bhagat Pharma Annual General Meeting
Chandra Bhagat Pharma Limited conducted its 23rd Annual General Meeting on September 1, 2026, covering annual accounts, director reappointment, capital increase, and warrant issuance.
Other board meeting date announcements
All →Axis Solutions Board Meeting Date
Axis Solutions Ltd intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter ended 30 September 2026. The notice also reiterates that the trading window remains closed until 48 hours after results.
Samyak International Board Meeting Date
Samyak International Ltd has notified BSE of a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the half year ended September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Airfloa Rail Technology Board Meeting Date
Airfloa Rail Technology intimated a board meeting on November 14, 2026 to approve unaudited standalone and consolidated results for the half year ended September 30, 2026. The filing is a meeting notice with no financial figures disclosed.
Maha Rashtra Apex Corporation Board Meeting Date
Maha Rashtra Apex Corporation has notified BSE and NSE of a board meeting on 12 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The meeting has not yet been held, so the agenda is only proposed.
East Buildtech Board Meeting Date
East Buildtech Ltd notified BSE that its board meeting on 14 November 2026 will consider unaudited financial results for the quarter and half year ended 30 September 2026. The notice also confirms the trading window stays closed until 16 November 2026.
Committed Cargo Care Board Meeting Date
Committed Cargo Care Limited has intimated a board meeting on November 13, 2026 to consider unaudited consolidated half-yearly results for September 2026. The trading window stays closed from October 1 to October 17, 2026.